Literature DB >> 19082259

[Antibiotic use in Mexico: review of problems and policies].

Anahí Dreser1, Veronika J Wirtz, Kitty K Corbett, Gabriela Echániz.   

Abstract

The inappropriate use of antibiotics signifies a risk for individual health and a waste of health resources. It triggers the development of antibiotic resistance, which increases expenditures and mortality related to infectious disease, and is hence considered a serious public health problem. The World Health Organization has thus recommended a series of strategies to be included within national pharmaceutical policies. In Mexico, diverse factors related to the inappropriate use of antibiotics have been documented. While the response has been mainly in the form of educational and managerial interventions directed toward physicians in public health services, as well as epidemiological surveillance, there is a paucity of research and interventions focused on consumers, pharmacies, and the private sector. Fundamentally, a comprehensive national strategy for antibiotics is not incorporated into health and pharmaceutical policies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082259     DOI: 10.1590/s0036-36342008001000009

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  8 in total

1.  Geographical and temporal dissemination of salmonellae isolated from domestic animal hosts in the Culiacan Valley, Mexico.

Authors:  Maribel Jiménez; Jaime Martínez-Urtaza; Cristobal Chaidez
Journal:  Microb Ecol       Date:  2011-01-28       Impact factor: 4.552

2.  The determinants of the antibiotic resistance process.

Authors:  Beatriz Espinosa Franco; Marina Altagracia Martínez; Martha A Sánchez Rodríguez; Albert I Wertheimer
Journal:  Infect Drug Resist       Date:  2009-04-17       Impact factor: 4.003

3.  Whole-genome sequence analysis of multidrug-resistant uropathogenic strains of Escherichia coli from Mexico.

Authors:  G L Paniagua-Contreras; E Monroy-Pérez; C E Díaz-Velásquez; A Uribe-García; A Labastida; F Peñaloza-Figueroa; P Domínguez-Trejo; L R García; F Vaca-Paniagua; S Vaca
Journal:  Infect Drug Resist       Date:  2019-08-01       Impact factor: 4.003

4.  Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico.

Authors:  Flor Y Ramírez Castillo; Francisco J Avelar González; Philippe Garneau; Francisco Márquez Díaz; Alma L Guerrero Barrera; Josée Harel
Journal:  Front Microbiol       Date:  2013-06-17       Impact factor: 5.640

5.  Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation.

Authors:  Anahí Dreser; Edna Vázquez-Vélez; Sandra Treviño; Veronika J Wirtz
Journal:  BMC Public Health       Date:  2012-12-06       Impact factor: 3.295

6.  Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Anahi Dreser; Hubert G M Leufkens; Veronika J Wirtz
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

7.  Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.

Authors:  Alan O Vázquez-Alvarez; Lorena Michele Brennan-Bourdon; Ana Rosa Rincón-Sánchez; María Cristina Islas-Carbajal; Selene G Huerta-Olvera
Journal:  BMC Pharmacol Toxicol       Date:  2017-12-08       Impact factor: 2.483

8.  Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City.

Authors:  Ramiro Sánchez-Huesca; Abel Lerma; Rebeca M E Guzmán-Saldaña; Claudia Lerma
Journal:  Antibiotics (Basel)       Date:  2020-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.